Citation: Rf. Rando et N. Nguyen-ba, Development of novel nucleoside analogues for use against drug resistant strains of HIV-1, DRUG DISC T, 5(10), 2000, pp. 465-476
Authors:
Alaoui-Ismaili, MH
Hamel, M
L'Heureux, L
Nicolas, O
Bilimoria, D
Labonte, P
Mounir, S
Rando, RF
Citation: Mh. Alaoui-ismaili et al., The hepatitis C virus NS5B RNA-dependent RNA polymerase activity and susceptibility to inhibitors is modulated by metal cations, J HUMAN VIR, 3(6), 2000, pp. 306-316
Authors:
Taylor, DL
Ahmed, PS
Tyms, AS
Wood, LJ
Kelly, LA
Chambers, P
Clarke, J
Bedard, J
Bowlin, TL
Rando, RF
Citation: Dl. Taylor et al., Drug resistance and drug combination features of the human immunodeficiency virus inhibitor, BCH-10652 [(+/-)-2 '-deoxy-3 '-oxa-4 '-thiocytidine, dOTC], ANTIVIR CHE, 11(4), 2000, pp. 291-301
Authors:
Bedard, J
May, S
L'Heureux, L
Stamminger, T
Copsey, A
Drach, J
Huffman, J
Chan, L
Jin, HL
Rando, RF
Citation: J. Bedard et al., Antiviral properties of a series of 1,6-naphthyridine and 7,8-dihydroisoquinoline derivatives exhibiting potent activity against human cytomegalovirus, ANTIM AG CH, 44(4), 2000, pp. 929-937
Authors:
Stoddart, CA
Moreno, ME
Linquist-Stepps, VD
Bare, C
Bogan, MR
Gobbi, A
Buckheit, RW
Bedard, J
Rando, RF
McCune, JM
Citation: Ca. Stoddart et al., Antiviral activity of 2 '-deoxy-3 '-oxa-4 '-thiocytidine (BCH-10652) against lamivudine-resistant human immunodeficiency virus type 1 in SCID-hu Thy/Liv mice, ANTIM AG CH, 44(3), 2000, pp. 783-786
Authors:
Jing, N
De Clercq, E
Rando, RF
Pallansch, L
Lackman-Smith, C
Lee, S
Hogan, ME
Citation: N. Jing et al., Stability-activity relationships of a family of G-tetrad forming oligonucleotides as potent HIV inhibitors - A basis for anti-HIV drug design, J BIOL CHEM, 275(5), 2000, pp. 3421-3430
Authors:
Taylor, DL
Ahmed, PS
Chambers, P
Tyms, AS
Bedard, J
Duchaine, J
Falardeau, G
Lavallee, JF
Brown, W
Rando, RF
Bowlin, T
Citation: Dl. Taylor et al., Pyrido [1,2a] indole derivatives identified as novel non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1, ANTIVIR CHE, 10(2), 1999, pp. 79-86
Authors:
Bedard, J
May, S
Barbeau, D
Yuen, L
Rando, RF
Bowlin, TL
Citation: J. Bedard et al., A high throughput colorimetric cell proliferation assay for the identification of human cytomegalovirus inhibitors, ANTIVIR RES, 41(1), 1999, pp. 35-43
Authors:
de Muys, JM
Gourdeau, H
Nguyen-Ba, N
Taylor, DL
Ahmed, PS
Mansour, T
Locas, C
Richard, N
Wainberg, MA
Rando, RF
Citation: Jm. De Muys et al., Anti-human immunodeficiency virus type 1 activity, intracellular metabolism, and pharmacokinetic evaluation of 2 '-deoxy-3 '-oxa-4 '-thiocytidine, ANTIM AG CH, 43(8), 1999, pp. 1835-1844
Authors:
Gu, ZX
Wainberg, MA
Nguyen-Ba, N
L'Heureux, L
de Muys, JM
Bowlin, TL
Rando, RF
Citation: Zx. Gu et al., Mechanism of action and in vitro activity of 1 ',3 '-dioxolanylpurine nucleoside analogues against sensitive and drug-resistant human immunodeficiency virus type 1 variants, ANTIM AG CH, 43(10), 1999, pp. 2376-2382